BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 31130411)

  • 21. Ultrasound Entropy Imaging of Nonalcoholic Fatty Liver Disease: Association with Metabolic Syndrome.
    Lin YH; Liao YY; Yeh CK; Yang KC; Tsui PH
    Entropy (Basel); 2018 Nov; 20(12):. PubMed ID: 33266617
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Relationship between Controlled Attenuation Parameter and Hepatic Steatosis as Assessed by Ultrasound in Alcoholic or Nonalcoholic Fatty Liver Disease.
    Ahn JM; Paik YH; Min SY; Cho JY; Sohn W; Sinn DH; Gwak GY; Choi MS; Lee JH; Koh KC; Paik SW; Yoo BC
    Gut Liver; 2016 Mar; 10(2):295-302. PubMed ID: 26347511
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Non-invasive assessment of liver fibrosis using acoustic structure quantification: comparison with transient elastography in chronic viral hepatitis.
    Nam TH; Park BJ; Sung DJ; Kim MJ; Han NY; Sim KC; Lee JH; Cho SB
    Abdom Radiol (NY); 2016 Feb; 41(2):239-47. PubMed ID: 26867905
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A Pilot Comparative Study of Quantitative Ultrasound, Conventional Ultrasound, and MRI for Predicting Histology-Determined Steatosis Grade in Adult Nonalcoholic Fatty Liver Disease.
    Paige JS; Bernstein GS; Heba E; Costa EAC; Fereirra M; Wolfson T; Gamst AC; Valasek MA; Lin GY; Han A; Erdman JW; O'Brien WD; Andre MP; Loomba R; Sirlin CB
    AJR Am J Roentgenol; 2017 May; 208(5):W168-W177. PubMed ID: 28267360
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prospective Evaluation of Hepatic Steatosis Using Ultrasound Attenuation Imaging in Patients with Chronic Liver Disease with Magnetic Resonance Imaging Proton Density Fat Fraction as the Reference Standard.
    Jeon SK; Lee JM; Joo I; Yoon JH; Lee DH; Lee JY; Han JK
    Ultrasound Med Biol; 2019 Jun; 45(6):1407-1416. PubMed ID: 30975533
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MR elastography is effective for the non-invasive evaluation of fibrosis and necroinflammatory activity in patients with nonalcoholic fatty liver disease.
    Costa-Silva L; Ferolla SM; Lima AS; Vidigal PVT; Ferrari TCA
    Eur J Radiol; 2018 Jan; 98():82-89. PubMed ID: 29279175
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Noninvasive Diagnosis of Nonalcoholic Fatty Liver Disease and Quantification of Liver Fat Using a New Quantitative Ultrasound Technique.
    Lin SC; Heba E; Wolfson T; Ang B; Gamst A; Han A; Erdman JW; O'Brien WD; Andre MP; Sirlin CB; Loomba R
    Clin Gastroenterol Hepatol; 2015 Jul; 13(7):1337-1345.e6. PubMed ID: 25478922
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hepatic steatosis assessment using ultrasound homodyned-K parametric imaging: the effects of estimators.
    Zhou Z; Zhang Q; Wu W; Lin YH; Tai DI; Tseng JH; Lin YR; Wu S; Tsui PH
    Quant Imaging Med Surg; 2019 Dec; 9(12):1932-1947. PubMed ID: 31929966
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Application of Deep Learning in Quantitative Analysis of 2-Dimensional Ultrasound Imaging of Nonalcoholic Fatty Liver Disease.
    Cao W; An X; Cong L; Lyu C; Zhou Q; Guo R
    J Ultrasound Med; 2020 Jan; 39(1):51-59. PubMed ID: 31222786
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Acoustic structure quantification ultrasound software proves imprecise in assessing liver fibrosis or cirrhosis in parenchymal liver diseases.
    Krämer C; Jaspers N; Nierhoff D; Kuhr K; Bowe A; Goeser T; Michels G
    Ultrasound Med Biol; 2014 Dec; 40(12):2811-8. PubMed ID: 25308947
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact factors and the optimal parameter of acoustic structure quantification in the assessment of liver fibrosis.
    Huang Y; Liu GJ; Liao B; Huang GL; Liang JY; Zhou LY; Wang F; Li W; Xie XY; Wang W; Lu MD
    Ultrasound Med Biol; 2015 Sep; 41(9):2360-7. PubMed ID: 26055966
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hepatic Alanine Differentiates Nonalcoholic Steatohepatitis From Simple Steatosis in Humans and Mice: A Proton MR Spectroscopy Study With Long Echo Time.
    Kim TH; Jun HY; Kim KJ; Lee YH; Lee MS; Choi KH; Yun KJ; Jeong YY; Jun CH; Cho EY; Yoon KH
    J Magn Reson Imaging; 2017 Nov; 46(5):1298-1310. PubMed ID: 28225569
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ultrasound-based hepatic fat quantification: current status and future directions.
    Seneviratne N; Fang C; Sidhu PS
    Clin Radiol; 2023 Mar; 78(3):187-200. PubMed ID: 36411088
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hepatic steatosis: quantification by proton density fat fraction with MR imaging versus liver biopsy.
    Idilman IS; Aniktar H; Idilman R; Kabacam G; Savas B; Elhan A; Celik A; Bahar K; Karcaaltincaba M
    Radiology; 2013 Jun; 267(3):767-75. PubMed ID: 23382293
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Non-alcoholic fatty liver disease-associated hepatocellular carcinoma: effect of hepatic steatosis on major hepatocellular carcinoma features at MRI.
    Thompson SM; Garg I; Ehman EC; Sheedy SP; Bookwalter CA; Carter RE; Roberts LR; Venkatesh SK
    Br J Radiol; 2018 Dec; 91(1092):20180345. PubMed ID: 30074820
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Quantitative ultrasound approaches for diagnosis and monitoring hepatic steatosis in nonalcoholic fatty liver disease.
    Pirmoazen AM; Khurana A; El Kaffas A; Kamaya A
    Theranostics; 2020; 10(9):4277-4289. PubMed ID: 32226553
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Computer-aided B-mode ultrasound diagnosis of hepatic steatosis: a feasibility study.
    Thijssen JM; Starke A; Weijers G; Haudum A; Herzog K; Wohlsein P; Rehage J; De Korte CL
    IEEE Trans Ultrason Ferroelectr Freq Control; 2008; 55(6):1343-54. PubMed ID: 18599422
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Acoustic structure quantification by using ultrasound Nakagami imaging for assessing liver fibrosis.
    Tsui PH; Ho MC; Tai DI; Lin YH; Wang CY; Ma HY
    Sci Rep; 2016 Sep; 6():33075. PubMed ID: 27605260
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Imaging evaluation of non-alcoholic fatty liver disease: focused on quantification.
    Lee DH
    Clin Mol Hepatol; 2017 Dec; 23(4):290-301. PubMed ID: 28994271
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Repeatability and Reproducibility of the Ultrasonic Attenuation Coefficient and Backscatter Coefficient Measured in the Right Lobe of the Liver in Adults With Known or Suspected Nonalcoholic Fatty Liver Disease.
    Han A; Andre MP; Deiranieh L; Housman E; Erdman JW; Loomba R; Sirlin CB; O'Brien WD
    J Ultrasound Med; 2018 Aug; 37(8):1913-1927. PubMed ID: 29359454
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.